Cybin Inc
Change company Symbol lookup
Select an option...
CYBN Cybin Inc
TTEK Tetra Tech Inc
EVEX+ Eve Holding Equity Warrants Exp 9 May 2027 *W EXP 05/09/2027
ATKR Atkore Inc
BAC-O Bank of America Corp
EFC Ellington Financial Inc
PKBK Parke Bancorp Inc
NOV Nov Inc

Based in Canada
Company profile

Cybin Inc. is a Canada-based biopharmaceutical company, working with a network of partners and scientists to create therapeutics for patients to address a multitude of mental health issues. The Company operates in Canada, the United States, United Kingdom and Ireland. The Company is focused on progressing psychedelics to therapeutics by engineering drug discovery platforms, drug delivery systems, formulation approaches and treatment regimens for mental health disorders. The Company’s products in pipeline include EMBARK, Kernel Flow, CYB003 (Deuterated Psilocybin Analog), CYB004 (Deuterated Dimethyltryptamine), and CYB005 (Phenethylamine Derivative). EMBARK is a Psilocybin for mental distress in frontline healthcare workers. Its subsidiaries include Cybin Corp., Natures Journey Inc., Serenity Life Sciences Inc., Cybin US Holdings Inc., Adelia Therapeutics Inc. and Cybin IRL Limited.


Last Trade
0.0163 (2.76%)
B/A Size

Market Hours

Closing Price
Day's Change
0.0205 (3.60%)
B/A Size
Day's High
Day's Low

10-day average volume:

Upcoming Events

CYBN's fiscal year ends in March
There are no upcoming events for CYBN

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
estimate range
Previous year's
February 10, 2022Q3 2022 Earnings Release-$0.08-$0.088 to -$0.072--
November 15, 2021Q2 2022 Earnings Release-$0.088-$0.11 to -$0.056--

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.